Thursday, November 07, 2019 12:13:23 PM
“ Our channel partner has expertise in creating custom orthopedic appliances and has been asked by a global provider of high-quality orthopedic devices to develop a product for proposed post-operative use, and two other anatomical sites which fall under existing OTC indicationsf”.
Our channel partner may be also considered to be a third party that seems to or maybe has the rights and license to either redesign or develop a product for post-operative use and two other anatomical sites!
Now who is this Global Provider? How big is this company? Could this company be one of the top ten big Pharmas?
Lot of questions to be answered from BIEL or should I say a lot of answers from BIEL.
I do believe there is some type of message in this update. What do you think?
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM